164 related articles for article (PubMed ID: 23085173)
41. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
Fiorino F; Perissutti E; Severino B; Santagada V; Cirillo D; Terracciano S; Massarelli P; Bruni G; Collavoli E; Renner C; Caliendo G
J Med Chem; 2005 Aug; 48(17):5495-503. PubMed ID: 16107148
[TBL] [Abstract][Full Text] [Related]
42. Structural basis for the β-adrenergic receptor subtype selectivity of the representative agonists and antagonists.
Roy KK; Saxena AK
J Chem Inf Model; 2011 Jun; 51(6):1405-22. PubMed ID: 21534556
[TBL] [Abstract][Full Text] [Related]
43. 5-HT4 and 5-HT2 receptors antagonistically influence gap junctional coupling between rat auricular myocytes.
Derangeon M; Bozon V; Defamie N; Peineau N; Bourmeyster N; Sarrouilhe D; Argibay JA; Hervé JC
J Mol Cell Cardiol; 2010 Jan; 48(1):220-9. PubMed ID: 19615378
[TBL] [Abstract][Full Text] [Related]
44. Mutagenesis analysis of the serotonin 5-HT2C receptor and a Caenorhabditis elegans 5-HT2 homologue: conserved residues of helix 4 and helix 7 contribute to agonist-dependent activation of 5-HT2 receptors.
Xie J; Dernovici S; Ribeiro P
J Neurochem; 2005 Jan; 92(2):375-87. PubMed ID: 15663485
[TBL] [Abstract][Full Text] [Related]
45. Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.
Zhao MM; Hwa J; Perez DM
Mol Pharmacol; 1996 Nov; 50(5):1118-26. PubMed ID: 8913343
[TBL] [Abstract][Full Text] [Related]
46. Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT(2A) receptors.
Blaazer AR; Smid P; Kruse CG
ChemMedChem; 2008 Sep; 3(9):1299-309. PubMed ID: 18666267
[TBL] [Abstract][Full Text] [Related]
47. A comprehensive study on the 5-hydroxytryptamine(3A) receptor binding of agonists serotonin and m-chlorophenylbiguanidine.
Hazai E; Joshi P; Skoviak EC; Suryanarayanan A; Schulte MK; Bikadi Z
Bioorg Med Chem; 2009 Aug; 17(16):5796-805. PubMed ID: 19640719
[TBL] [Abstract][Full Text] [Related]
48. Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT
Carpenter J; Wang Y; Wu G; Feng J; Ye XY; Morales CL; Broekema M; Rossi KA; Miller KJ; Murphy BJ; Wu G; Malmstrom SE; Azzara AV; Sher PM; Fevig JM; Alt A; Bertekap RL; Cullen MJ; Harper TM; Foster K; Luk E; Xiang Q; Grubb MF; Robl JA; Wacker DA
J Med Chem; 2017 Jul; 60(14):6166-6190. PubMed ID: 28635286
[TBL] [Abstract][Full Text] [Related]
49. The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins.
Bécamel C; Gavarini S; Chanrion B; Alonso G; Galéotti N; Dumuis A; Bockaert J; Marin P
J Biol Chem; 2004 May; 279(19):20257-66. PubMed ID: 14988405
[TBL] [Abstract][Full Text] [Related]
50. Prediction of 5-HT3 receptor agonist-binding residues using homology modeling.
Reeves DC; Sayed MF; Chau PL; Price KL; Lummis SC
Biophys J; 2003 Apr; 84(4):2338-44. PubMed ID: 12668442
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and Biological Evaluation of Disubstituted Pyrimidines as Selective 5-HT
Kim J; Kim YJ; Londhe AM; Pae AN; Choo H; Kim HJ; Min SJ
Molecules; 2019 Sep; 24(18):. PubMed ID: 31491978
[TBL] [Abstract][Full Text] [Related]
52. A novel identification approach for discovery of 5-HydroxyTriptamine 2A antagonists: combination of 2D/3D similarity screening, molecular docking and molecular dynamics.
Kumar R; Jade D; Gupta D
J Biomol Struct Dyn; 2019 Mar; 37(4):931-943. PubMed ID: 29468945
[TBL] [Abstract][Full Text] [Related]
53. Homology modeling of the human 5-HT1A, 5-HT 2A, D1, and D2 receptors: model refinement with molecular dynamics simulations and docking evaluation.
Yap BK; Buckle MJ; Doughty SW
J Mol Model; 2012 Aug; 18(8):3639-55. PubMed ID: 22354276
[TBL] [Abstract][Full Text] [Related]
54. 5-HT
Peng Y; McCorvy JD; Harpsøe K; Lansu K; Yuan S; Popov P; Qu L; Pu M; Che T; Nikolajsen LF; Huang XP; Wu Y; Shen L; Bjørn-Yoshimoto WE; Ding K; Wacker D; Han GW; Cheng J; Katritch V; Jensen AA; Hanson MA; Zhao S; Gloriam DE; Roth BL; Stevens RC; Liu ZJ
Cell; 2018 Feb; 172(4):719-730.e14. PubMed ID: 29398112
[TBL] [Abstract][Full Text] [Related]
55. Molecular modeling and docking study on dopamine D2-like and serotonin 5-HT2A receptors.
Duan X; Zhang M; Zhang X; Wang F; Lei M
J Mol Graph Model; 2015 Apr; 57():143-55. PubMed ID: 25728902
[TBL] [Abstract][Full Text] [Related]
56. Molecular modeling of adenosine receptors.
Martinelli A; Ortore G
Methods Enzymol; 2013; 522():37-59. PubMed ID: 23374179
[TBL] [Abstract][Full Text] [Related]
57. New strategy for receptor-based pharmacophore query construction: a case study for 5-HT₇ receptor ligands.
Kurczab R; Bojarski AJ
J Chem Inf Model; 2013 Dec; 53(12):3233-43. PubMed ID: 24245803
[TBL] [Abstract][Full Text] [Related]
58. On the structural and mechanistic basis of function, classification, and ligand design for 5-HT receptors.
Weinstein H; Osman R
Neuropsychopharmacology; 1990; 3(5-6):397-409. PubMed ID: 2078275
[TBL] [Abstract][Full Text] [Related]
59. Effect of Bulky
Soares BA; Yempala T; Martínez-Afani D; Acevedo-Fuentes W; Brea J; Loza MI; Cimadevila M; Cassels BK
ACS Chem Neurosci; 2024 Feb; 15(3):608-616. PubMed ID: 38241462
[TBL] [Abstract][Full Text] [Related]
60. A functional selectivity mechanism at the serotonin-2A GPCR involves ligand-dependent conformations of intracellular loop 2.
Perez-Aguilar JM; Shan J; LeVine MV; Khelashvili G; Weinstein H
J Am Chem Soc; 2014 Nov; 136(45):16044-54. PubMed ID: 25314362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
